{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:41:19Z","timestamp":1793832079190,"version":"4.6.1"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation Research"],"published-print":{"date-parts":[[2017,4,14]]},"abstract":"<jats:p>In the era of drug-eluting stents, large-scale randomized trials and all-comer registries have shown excellent clinical results. However, even the latest-generation drug-eluting stent has not managed to address all the limitations of permanent metallic coronary stents, such as the risks of target lesion revascularization, neoatherosclerosis, preclusion of late lumen enlargement, and the lack of reactive vasomotion. Furthermore, the risk of very late stent, although substantially reduced with newer-generation drug-eluting stent, still remains. These problems were anticipated to be solved with the advent of fully biodegradable devices. Fully bioresorbable coronary scaffolds have been designed to function transiently to prevent acute recoil, but have retained the capability to inhibit neointimal proliferation by eluting immunosuppressive drugs. Nevertheless, long-term follow-up data of the leading bioresorbable scaffold (Absorb) are becoming available and have raised a concern about the relatively higher incidence of scaffold thrombosis. To reduce the rate of clinical events, improvements in the device, as well as implantation procedure, are being evaluated. This review will focus on the current CE-mark approved bioresorbable scaffolds, their basic characteristics, and clinical results. In addition, we summarize the current limitations of bioresorbable scaffold and their possible solutions.<\/jats:p>","DOI":"10.1161\/circresaha.117.310275","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T16:00:26Z","timestamp":1492099226000},"page":"1341-1352","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":159,"title":["Bioresorbable Scaffold"],"prefix":"10.1161","volume":"120","author":[{"given":"Yohei","family":"Sotomi","sequence":"first","affiliation":[{"name":"From the Department of Cardiology, Academic Medical Center, University of Amsterdam, the Netherlands (Y.S., C.C.); ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands (Y.O., E.T.); Cardialysis, Rotterdam, the Netherlands (Y.O.); CVPath, Institute Inc, Gaithersburg, MD (R.V.); Department of Cardiology (NSK), Houston Methodist DeBakey Heart and Vascular Center, Texas (N.S.K.); and NHLI, Imperial College London, United Kingdom (P.W.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology, Academic Medical Center, University of Amsterdam, the Netherlands (Y.S., C.C.); ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands (Y.O., E.T.); Cardialysis, Rotterdam, the Netherlands (Y.O.); CVPath, Institute Inc, Gaithersburg, MD (R.V.); Department of Cardiology (NSK), Houston Methodist DeBakey Heart and Vascular Center, Texas (N.S.K.); and NHLI, Imperial College London, United Kingdom (P.W.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Collet","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology, Academic Medical Center, University of Amsterdam, the Netherlands (Y.S., C.C.); ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands (Y.O., E.T.); Cardialysis, Rotterdam, the Netherlands (Y.O.); CVPath, Institute Inc, Gaithersburg, MD (R.V.); Department of Cardiology (NSK), Houston Methodist DeBakey Heart and Vascular Center, Texas (N.S.K.); and NHLI, Imperial College London, United Kingdom (P.W.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Tenekecioglu","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology, Academic Medical Center, University of Amsterdam, the Netherlands (Y.S., C.C.); ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands (Y.O., E.T.); Cardialysis, Rotterdam, the Netherlands (Y.O.); CVPath, Institute Inc, Gaithersburg, MD (R.V.); Department of Cardiology (NSK), Houston Methodist DeBakey Heart and Vascular Center, Texas (N.S.K.); and NHLI, Imperial College London, United Kingdom (P.W.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Virmani","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology, Academic Medical Center, University of Amsterdam, the Netherlands (Y.S., C.C.); ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands (Y.O., E.T.); Cardialysis, Rotterdam, the Netherlands (Y.O.); CVPath, Institute Inc, Gaithersburg, MD (R.V.); Department of Cardiology (NSK), Houston Methodist DeBakey Heart and Vascular Center, Texas (N.S.K.); and NHLI, Imperial College London, United Kingdom (P.W.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Kleiman","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology, Academic Medical Center, University of Amsterdam, the Netherlands (Y.S., C.C.); ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands (Y.O., E.T.); Cardialysis, Rotterdam, the Netherlands (Y.O.); CVPath, Institute Inc, Gaithersburg, MD (R.V.); Department of Cardiology (NSK), Houston Methodist DeBakey Heart and Vascular Center, Texas (N.S.K.); and NHLI, Imperial College London, United Kingdom (P.W.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[{"name":"From the Department of Cardiology, Academic Medical Center, University of Amsterdam, the Netherlands (Y.S., C.C.); ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands (Y.O., E.T.); Cardialysis, Rotterdam, the Netherlands (Y.O.); CVPath, Institute Inc, Gaithersburg, MD (R.V.); Department of Cardiology (NSK), Houston Methodist DeBakey Heart and Vascular Center, Texas (N.S.K.); and NHLI, Imperial College London, United Kingdom (P.W.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.02.086"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17275-9"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.666800"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067722"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.10.026"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/joic.12082"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.666826"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.049"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607991"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr384"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.03.042"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6107(02)00052-4"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio0274"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2596"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-11-1416"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.05.017"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV9I11A217"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-016-1018-6"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht545"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-16-00472"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.2015.1089172"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60415-8"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0b013e328333f550"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.05.011"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY15M02_03"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw196"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00447-X"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY16M06_01"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61765-6"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht542"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV5IFA2"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.971606"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV5IFA3"},{"key":"e_1_3_3_36_2","first-page":"290","article-title":"Biodegradable bone repair materials. Synthetic polymers and ceramics.","author":"Hollinger JO","year":"1986","unstructured":"Hollinger JO, Battistone GC. Biodegradable bone repair materials. Synthetic polymers and ceramics. Clin Orthop Relat Res. 1986:290\u2013305.","journal-title":"Clin Orthop Relat Res"},{"key":"e_1_3_3_37_2","volume-title":"Natural-Origin Degradable Materials Biodegradable Systems in Tissue Engineering and Regenerative Medicine","author":"Marques AP","year":"2004","unstructured":"Marques AP, Hunt JA, Reis R. Natural-Origin Degradable Materials Biodegradable Systems in Tissue Engineering and Regenerative Medicine. Amsterdam, the Netherlands: Elsevier, CRC Press; 2004."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.921528"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.07.007"},{"key":"e_1_3_3_41_2","unstructured":"Elixir. http:\/\/elixirmedical.com\/index.php%3Fpage=ous-desolve. Accessed March 27 2017."},{"key":"e_1_3_3_42_2","article-title":"ARTDIVA.","author":"Lafont A","year":"2014","unstructured":"Lafont A. ARTDIVA. Presented at BRS. July 26, 2014.","journal-title":"Presented at BRS"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.08.117"},{"key":"e_1_3_3_44_2","article-title":"Featured Lecture: The Biotronik Magnesium DREAMS Scaffold: Pivotal BIOSOLVE-II Results.","author":"Haude M","year":"2015","unstructured":"Haude M. Featured Lecture: The Biotronik Magnesium DREAMS Scaffold: Pivotal BIOSOLVE-II Results. Presented at TCT. October 16, 2015.","journal-title":"Presented at TCT"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cossms.2009.04.001"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV8I12A218"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms141224492"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.corsci.2011.12.026"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32050-5"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY16M09_01"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509038"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.054"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv500"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.12.017"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01039-9"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.019"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.10.027"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2014.06.016"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.12.004"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4725.16.04238-9"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-16-00471"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.08.853"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.002518"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jew329"},{"key":"e_1_3_3_65_2","article-title":"Desolve Nx, Cx and Amity: Unique Properties and Results From 150 \u03bcm To 120 \u03bcm.","author":"Abizaid A","year":"2016","unstructured":"Abizaid A. Desolve Nx, Cx and Amity: Unique Properties and Results From 150 \u03bcm To 120 \u03bcm. Presented at TCT. November 1, 2016.","journal-title":"Presented at TCT"},{"key":"e_1_3_3_66_2","article-title":"FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease.","author":"Abizaid A","year":"2016","unstructured":"Abizaid A. FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease. Presented at TCT. November 1, 2016.","journal-title":"Presented at TCT"},{"key":"e_1_3_3_67_2","article-title":"MeRes100\u2014Design Specifications and the 6-months MeRes-1 Results.","author":"Seth A","year":"2016","unstructured":"Seth A. MeRes100\u2014Design Specifications and the 6-months MeRes-1 Results. Presented at TCT. November 1, 2016.","journal-title":"Presented at TCT"},{"key":"e_1_3_3_68_2","article-title":"FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease.","author":"Colombo A","year":"2016","unstructured":"Colombo A. FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease. Presented at TCT. November 1, 2016.","journal-title":"Presented at TCT"},{"key":"e_1_3_3_69_2","article-title":"FIRESORB PLLA-Based Sirolimus-Eluting Scaffold: 6-Month FUTURE-I Results.","author":"Xu B","year":"2016","unstructured":"Xu B. FIRESORB PLLA-Based Sirolimus-Eluting Scaffold: 6-Month FUTURE-I Results. Presented at TCT. November 1, 2016.","journal-title":"Presented at TCT"},{"key":"e_1_3_3_70_2","article-title":"Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6\u20139 Month Results).","author":"Geuns R-Jv","year":"2016","unstructured":"Geuns R-Jv. Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6\u20139 Month Results). Presented at TCT. November 2, 2016.","journal-title":"Presented at TCT"},{"key":"e_1_3_3_71_2","article-title":"MIRAGE: Design Novelty and 1-Year Results With a Microfiber-Based BRS.","author":"Serruys PW","year":"2016","unstructured":"Serruys PW. MIRAGE: Design Novelty and 1-Year Results With a Microfiber-Based BRS. Presented at TCT. November 1, 2016.","journal-title":"Presented at TCT"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.08.019"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1955"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.01023.x"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.03.027"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.07.026"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.03.022"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-16-0818"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-016-0856-6"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-16-00247"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV12I14A277"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000404"}],"container-title":["Circulation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCRESAHA.117.310275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T23:53:43Z","timestamp":1715558023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCRESAHA.117.310275"}},"subtitle":["The Emerging Reality and Future Directions"],"short-title":[],"issued":{"date-parts":[[2017,4,14]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,4,14]]}},"alternative-id":["10.1161\/CIRCRESAHA.117.310275"],"URL":"https:\/\/doi.org\/10.1161\/circresaha.117.310275","relation":{},"ISSN":["0009-7330","1524-4571"],"issn-type":[{"value":"0009-7330","type":"print"},{"value":"1524-4571","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,14]]},"assertion":[{"value":"2017-04-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}